Ascendis Pharma A/S 20-F for FY2024
Ascendis Pharma A/S (ASND)
20-F
2025-02-12
For: 2024-12-31
View Original
Added on
April 11, 2026
About this 20-F
Ascendis Pharma A/S filed this 20-F on February 12, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 363.64M EUR
- up 36.3% from 266.72M EUR a year earlier
- Net loss
- 378.08M EUR
- compared with a net loss of 481.45M EUR a year earlier
- Diluted EPS
- -6.53 EUR
- compared with -8.55 EUR a year earlier